Abstract
A mild, efficient and highly convenient protocol is reported for the synthesis of a series of polyphenolic amides using ferric exchanged montmorillonite as a strong solid acid catalyst. This heterogeneous catalyst has an advantage of a strikingly simple work up procedure over conventional homogeneous acids. The catalyst is recoverable and recyclable.
Keywords: Amidation, montmorillonite, phenolic acids, polyphenolic amides, esters, medicine, antibacterial, antioxidant, anti-inflammatory, antimutagenic
Letters in Organic Chemistry
Title: Simple, Clean and Highly Efficient Synthesis of Polyphenolic Amides Catalysed by Ferric Exchanged Montmorillonite
Volume: 8 Issue: 9
Author(s): Dhrubajyoti Mahanta and Jyotirekha G. Handique
Affiliation:
Keywords: Amidation, montmorillonite, phenolic acids, polyphenolic amides, esters, medicine, antibacterial, antioxidant, anti-inflammatory, antimutagenic
Abstract: A mild, efficient and highly convenient protocol is reported for the synthesis of a series of polyphenolic amides using ferric exchanged montmorillonite as a strong solid acid catalyst. This heterogeneous catalyst has an advantage of a strikingly simple work up procedure over conventional homogeneous acids. The catalyst is recoverable and recyclable.
Export Options
About this article
Cite this article as:
Mahanta Dhrubajyoti and G. Handique Jyotirekha, Simple, Clean and Highly Efficient Synthesis of Polyphenolic Amides Catalysed by Ferric Exchanged Montmorillonite, Letters in Organic Chemistry 2011; 8 (9) . https://dx.doi.org/10.2174/157017811799304241
DOI https://dx.doi.org/10.2174/157017811799304241 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Basis of the Anti-Inflammatory Effects of Terpenoids
Inflammation & Allergy - Drug Targets (Discontinued) The Role of Endostatin in Rheumatoid Arthritis
Current Rheumatology Reviews New Tools for Membrane Protein Research
Current Protein & Peptide Science Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
Current Molecular Medicine Chemical and Pharmacological Aspects of Heteroaryl-Nitrones
Current Medicinal Chemistry Novel Therapeutic Targets for the Treatment of Depression
Current Medicinal Chemistry - Central Nervous System Agents Treatment of Psoriasis: A Comprehensive Review of Entire Therapies
Current Drug Safety Mucosal Epithelium in Health and Disease
Current Molecular Medicine ACE Inhibitors and ARBs for Obesity-Related Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pyrazoles as Promising Scaffold for the Synthesis of Anti-Inflammatory and/or Antimicrobial Agent: A Review
Mini-Reviews in Medicinal Chemistry Amyloid Beta: The Alternate Hypothesis
Current Alzheimer Research Recommendations for the Use of Therapeutic Plasma
Current Vascular Pharmacology Immunomodulation in Polytrauma and Polymicrobial Sepsis - Where Do We Stand?
Recent Patents on Inflammation & Allergy Drug Discovery Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence
Current Psychiatry Reviews The Impact of Immunosuppressive Drugs on the Analysis of T-Cell Activation
Current Medicinal Chemistry High-throughput Genotyping Methods for Pharmacogenomic Studies
Current Pharmacogenomics Preface [Hot topic: Psoriasis (Guest Editor: Giampiero Girolomoni)]
Current Drug Targets - Inflammation & Allergy Systemic Therapeutic Gene Delivery for Cancer: Crafting Paris Arrow
Current Gene Therapy Profiling Drug Membrane Transport via Immobilized Artificial Membrane Chromatography
Current Pharmaceutical Analysis Prospects of miRNA-Based Therapy for Pancreatic Cancer
Current Drug Targets